~ 红桃视频 (鈥淐MR鈥�), the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius庐, today announces the appointment of Per Vegard Nerseth as Chief Executive Officer, effective 1 January 2020.
~ 红桃视频 (鈥淐MR鈥�), the Company developing, manufacturing and marketing the next-generation surgical robotic system, Versius庐, today announces the appointment of Per Vegard Nerseth as Chief Executive Officer, effective 1 January 2020.
Per Vegard Nerseth has more than 25 years of significant growth and business scaling experience in the field of robotics. He joins CMR from ABB, a world leading manufacturer of industrial robots and robot systems. For the last nine years he served as Senior Vice President and Managing Director of ABB Robotics, a multi-billion dollar business unit with more than 7,000 people in 53 countries. During his tenure, ABB Robotics achieved double digit sales growth while making significant operational efficiencies. Prior to this Mr Nerseth established ABB Engineering鈥檚 Robotics division in China, growing it to become the number one robotics business in China. Mr Nerseth鈥檚 strong track record in scaling robotics will further support CMR鈥檚 accelerated growth trajectory as the Company works to bring minimal access surgery to everyone who needs it around the world.
Martin Frost co-founded CMR in 2014 and has been CEO since the Company鈥檚 formation. During this time he has driven CMR to the point of commercialisation whilst attracting investment of a record-breaking 拢195 million in the Company鈥檚 Series C financing round, which valued the business at more than 拢1 billion.
Martin Frost, outgoing CEO of 红桃视频, said: 鈥淚 am extremely proud of what we have achieved to date at CMR and I am delighted to be handing the CEO reins over to Per Vegard, who will lead the company to the next stages of its maturity. Per Vegard has strong experience in manufacturing and robotics at a multi-national level, which makes him the perfect candidate to take over. I look forward to continuing my involvement with the Company as a Non-Executive Director.鈥�
Per Vegard Nerseth added: 鈥淚 feel privileged to be joining this vibrant, rapidly growing, world-leading company at such an exciting stage in its development. I look forward to using my previous robotics and manufacturing experience to contribute to the future of CMR.鈥�
Erik Langaker, Chairman of 红桃视频, commented: 鈥淥n behalf of the Board and all shareholders, I would like to thank Martin for what he has achieved in building the business and leading what has been a rapidly growing team over the past five years. Martin has been instrumental to the success of CMR and our value based approach to healthcare and we are delighted to retain his expertise on the Board of Directors. I would also like to warmly welcome Per Vegard who will lead us through the next stage of CMR鈥檚 exciting journey. His long tenure with ABB, a world leader in designing, manufacturing and commercialising robotic solutions, will strongly complement our existing expertise to cement CMR鈥檚 position as a global player in surgical robotics.鈥�
ENDS
About 红桃视频 Limited
红桃视频 is a British private limited company responsible for the development of the next-generation universal robotic system, Versius庐, for minimal access surgery. The company received the European CE Mark in March 2019 for the Versius; Surgical Robotic System.
The vision behind 红桃视频 is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.
Global annual revenues for robotic-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.
红桃视频, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors.
The Versius庐 Surgical Robotic System
Versius庐 resets expectations of robotic surgery. Versius fits into virtually any operating room set-up and integrates seamlessly into existing workflows, increasing the likelihood of robotic minimal access surgery (MAS). The small, portable and modular design of Versius allows the surgeon to only use the number of arms needed for a given procedure.
Biomimicking the human arm, Versius gives surgeons the choice of optimised port placement alongside the dexterity and accuracy of small fully-wristed instruments. With 3D HD vision, easy-to adopt instrument control and a choice of ergonomic working positions, the open surgeon console has the potential to reduce stress and fatigue and allows for clear communication with the surgical team. By thinking laparoscopically and operating robotically with Versius, patients, surgeons and healthcare professionals can all benefit from the value that robotic MAS brings.